Fumihiro Tanaka, MD | Authors

Jaymi McKay

919 Washington SE


Postoperative Adjuvant Chemotherapy for Non-Small-Cell Lung Cancer

September 02, 1997

Given that no therapeutic methods of postoperative adjuvant chemotherapy for non-small-cell lung cancer have been established, we selected UFT (tegafur and uracil) for investigation because UFT is less injurious to the host